| |
Univariate analysis
|
Maltivariate
|
|---|
| |
Coefficient [95% CI]
|
P value
|
Coefficient [95% CI]
|
P value
|
|---|
|
Age (per 5 years)
|
−1.15 [−3.74 to 1.43]
|
0.375
|
−1.58 [−3.74 to 0.58]
|
0.149
|
|
Female (vs male)
|
5.03 [−2.40 to 12.46]
|
0.182
|
5.63 [−1.64 to 12.91]
|
0.127
|
|
PS 1 (vs PS 0)
|
9.16 [−1.37 to 19.68]
|
0.087
|
3.34 [−4.82 to 11.49]
|
0.418
|
|
Serum albumin
|
−3.53 [−11.89 to 4.84]
|
0.404
|
−1.28 [−9.14 to 6.59]
|
0.747
|
|
Cisplatin dose (per 5 mg/ml)
|
−1.41 [−1.57 to 4.38]
|
0.348
|
1.24 [−1.40 to 3.90]
|
0.35
|
|
Regular use drug
| | | | |
|
NSAIDs
|
7.63 [−1.75 to 17.02]
|
0.109
|
2.98 [−5.25 to 11.21]
|
0.473
|
|
Mg for purgative
|
0.54 [−7.25 to 8.34]
|
0.89
|
−3.67 [−10.10 to 2.76]
|
0.259
|
|
Anorexia (grade 2 or more)
|
−2.13 [−9.51 to 5.24]
|
0.566
|
2.19 [−5.31 to 9.70]
|
0.562
|
|
Mg infusion
|
−14.73 [−21.25 to −8.21]
|
<0.001
|
−15.28 [−21.99 to −8.57]
|
<0.001
|
|
Low volume hydration
|
−3.40 [−11.33 to 4.53]
|
0.396
|
22.31 [9.16 to 35.46]
|
0.001
|
- CI, confidential interval; PS, performance status; NSAIDs, non-steroid anti-Inflammatory drugs; Mg for purgative, Magnesium containing medications for purgative.
